Registro:

Referencias:

• Stampfer, M., Malinow, R., Willett, W., Newcomer, L.M., Upson, B., Ullmann, D., A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians (1992) JAMA, 268, pp. 877-881
• Brattstrom, L., Lindgren, A., Hyperhomocysteinemia as a risk factor for stroke (1992) Neurol Res, 14, pp. 81-84
• Malinow, M.R., Kang, S.S., Taylor, L.M., Wong, P.W., Coull, B., Inahara, T., Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease (1989) Circulation, 79, pp. 1180-1188
• D'Angelo, A., Selhub, J., Homocysteine and thrombotic disease (1997) Blood, 90, pp. 1-11
• Finkelstein, J., Martin, J., Methionine metabolism in mammals. Distribution of homocysteine between competing pathways (1984) J Biol Chem, 259, pp. 9508-9513
• Blom, H.J., Consequences of homocysteine export and oxidation in the vascular system (2000) Semin Thromb Hemost, 26, pp. 227-232
• Ueland, M., Homocysteine species as components of plasma redox thiol status (1995) Clin Chem, 41, pp. 340-342
• Schneede, J., Refsum, H., Ueland, P.M., Biological and environmental determinants of plasma homocysteine (2000) Semin Thromb Hemost, 26, pp. 263-279
• Ueland, P.M., Refsum, H., Stabler, S.P., Malinow, M.R., Andersson, A., Allen, R.H., Total homocysteine in plasma or serum: Methods and clinical applications (1993) Clin Chem, 39, pp. 1764-1779
• Castanon, M., Lauricella, A., Kordich, L., Quintana, I., Plasma homocysteine cutoff values for venous thrombosis (2007) Clin Chem Lab Med, 45, pp. 232-236
• Coppola, A., Giovanni, D., De Stefano, V., Mancini, F., Cerbone, A., Di Minno, G., Homocysteine, coagulation, platelet function, and thrombosis (2000) Semin Thromb Hemost, 26, pp. 243-254
• Dionisio, N., Jardin, I., Salido, G.M., Rosado, J.A., Homocysteine, intracellular signaling and thrombotic disorders (2010) Curr Med Chem, 17, pp. 3109-3119
• Awan, Z., Aljenedil, S., Rosenblatt, D.S., Cusson, J., Gilfix, B.M., Genest, J., Severe hyperhomocysteinemia due to cystathionine β-synthase deficiency, and Factor v Leiden mutation in a patient with recurrent venous thrombosis (2014) Thromb J, 12, p. 30
• Ebbesen, L.S., Ingerslev, J., Folate deficiency-induced hyperhomocysteinemia attenuates, and folic acid supplementation restores, the functional activities of rat coagulation factors XII, X, and II (2005) J Nutr, 135, pp. 1836-1840
• Glueck, C.J., Pranikoff, J., Aregawi, D., Haque, M., Zhu, B., Tracy, T., The factor v Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: Etiologies for sporadic miscarriage (2005) Metabolism, 54, pp. 1345-1349
• Ventura, P., Cobelli, M., Marietta, M., Panini, R., Rosa, M.C., Salvioli, G., Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor v Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis (2004) Cerebrovasc Dis, 17, pp. 153-159
• Cellai, A.P., Lami, D., Antonucci, E., Liotta, A.A., Rogolino, A., Fedi, S., Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity (2014) J Thromb Thrombolysis, 38, pp. 45-49
• Jacobsen, D.W., Homocysteine targeting of plasma proteins in hemodialysis patients (2006) Kidney Int, 69, pp. 787-789
• Jakubowski, H., Quality control in ARNt charging - Editing of homocysteine (2011) Acta Biochim Pol, 58, pp. 149-163
• Hoffman, M., Alterations of fibrinogen structure in human disease (2008) Cardiovasc Hematol Agents Med Chem, 6, pp. 206-211
• Perla-Kajan, J., Marczak, L., Kajan, L., Skowronek, P., Twardowski, T., Jakubowski, H., Modification by homocysteine thiolactone affects redox status of cytochrome c (2007) Biochemistry, 46, pp. 6225-6231
• Sibrian-Vazquez, M., Escobedo, J.O., Lim, S., Samoei, G.K., Strongin, R.M., Homocystamides promote free-radical and oxidative damage to proteins (2010) Proc Natl Acad Sci USA, 107, pp. 551-554
• Jakubowski, H., Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease (2002) J Biol Chem, 277, pp. 30425-30428
• Chwatko, G., Jakubowski, H., The determination of homocysteine- thiolactone in human plasma (2005) Anal Biochem, 337, pp. 271-277
• Zinellu, A., Sotgia, S., Scanu, B., Pisanu, E., Sanna, M., Sati, S., Determination of homocysteine thiolactone, reduced homocysteine, homocystine, homocysteine-cys- teine mixed disulfide, cysteine and cystine in a reaction mixture by overimposed pressure/voltage capillary electrophoresis (2010) Talanta, 82, pp. 1281-1285
• Arora, B., Narayanasamy, A., Nirmal, J., Halder, N., Patnaik, S., Ravi, A.K., Development and validation of a LCMS/MS method for homocysteine thiolactone in plasma and evaluation of its stability in plasma samples (2014) J Chromatogr B Analyt Technol Biomed Life Sci, 944, pp. 49-54
• Zaabczyk, M., Glowacki, R., Machnik, A., Herod, P., Kazek, G., Jakubowski, H., Elevated concentrations of Nβ-homocysteinyl-lysine isopeptide in acute myocardial infarction: Links with ADMA formation (2011) Clin Chem Lab Med, 49, pp. 729-735
• Undas, A., Perła, J., Lacinski, M., Trzeciak, W., Kázmierski, R., Jakubowski, H., Autoantibodies against N-homocysteinylated proteins in humans: Implications for atherosclerosis (2004) Stroke, 35, pp. 1299-1304
• Undas, A., Stepien, E., Glowacki, R., Tisonczyk, J., Tracz, W., Jakubowski, H., Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia (2006) Thromb Haemost, 96, pp. 342-347
• Undas, A., Jankowski, M., Twardowska, M., Padjas, A., Jakubowski, H., Szczeklik, A., Antibodies to N-homocysteinylated albumin as a marker for early-onset coronary artery disease in men (2005) Thromb Haemost, 93, pp. 346-350
• Sharma, G.S., Kumar, T., Dar, T.A., Singh, L.R., Protein N-homocysteinylation: From cellular toxicity to neurodegeneration (2015) Biochim Biophys Acta, 1850, pp. 2239-2245
• Gurda, D., Handschuh, L., Kotkowiak, W., Jakubowski, H., Homocysteine thiolactone and N-homocysteinylated protein induce pro-atherogenic changes in gene expression in human vascular endothelial cells (2015) Amino Acids, 47, pp. 1319-1339
• Jakubowski, H., Protein homocysteinylation: Possible mechanism underlying pathological consequences of elevated homocysteine levels (1999) FASEB J, 13, pp. 2277-2283
• Knorre, D.G., Kudryashova, N.V., Godovikova, T.S., Chemical and functional aspects of posttranslational modification of proteins (2009) Acta Naturae, 1, pp. 29-51
• Jakubowski, H., Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease (2002) J Biol Chem, 277, pp. 30425-30428
• Glowacki, R., Jakubowski, H., Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation (2004) J Biol Chem, 279, pp. 10864-10871
• Genoud, V., Castanon, M., Lauricella, A.M., Quintana, I., Characterization of N-homocysteinylated albumin adducts (2014) Protein J, 33, pp. 85-91
• Marczak, L., Sikora, M., Stobiecki, M., Jakubowski, H., Analysis of site-specific N-homocysteinylation of human serum albumin in vitro and in vivo using MALDI-TOF and LC-MS/MS mass spectrometry (2011) J Proteomics, 74, pp. 967-974
• Sikora, M., Marczak, L., Twardowski, T., Stobiecki, M., Jakubowski, H., Direct monitoring of albumin lysine-525 N-homocysteinylation in human serum by liquid chromatography/mass spectrometry (2010) Anal Biochem, 405, pp. 132-134
• Smith, A.D., Smith, S.M., De Jager, C.A., Whitbread, P., Johnston, C., Agacinski, G., Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial (2010) PLoS One, 5, p. e12244
• Paoli, P., Sbrana, F., Tiribilli, B., Caselli, A., Pantera, B., Cirri, P., Protein N-homocysteinylation induces the formation of toxic amyloid-like protofibrils (2010) J Mol Biol, 400, pp. 889-907
• Genoud, V., Lauricella, A.M., Kordich, L.C., Quintana, I., Impact of homocysteine-thiolactone on plasma fibrin networks (2014) J Thromb Thrombolysis, 38, pp. 540-545
• Chung, Y.C., Kruyer, A., Yao, Y., Feierman, E., Richards, A., Strickland, S., Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction (2016) J Thromb Haemost, 14, pp. 1442-1452
• Chwatko, G., Boers, G.H., Strauss, K.A., Shih, D.M., Jakubowski, H., Mutations in methylenetetrahydrofolate reductase or cystathionine β-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice (2007) FASEB J, 21, pp. 1707-1713

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------